Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
32.46
-0.01 (-0.03%)
At close: Jun 18, 2025, 4:00 PM
32.48
+0.02 (0.06%)
After-hours: Jun 18, 2025, 4:20 PM EDT
HRMY Employees
Harmony Biosciences Holdings had 268 employees as of December 31, 2024. The number of employees increased by 22 or 8.94% compared to the previous year.
Employees
268
Change (1Y)
22
Growth (1Y)
8.94%
Revenue / Employee
$2,779,299
Profits / Employee
$569,847
Market Cap
1.87B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
HRMY News
- 8 days ago - Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025 - Business Wire
- 14 days ago - Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation - Business Wire
- 15 days ago - Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - Business Wire
- 6 weeks ago - Harmony Biosciences Holdings, Inc. (HRMY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance - Business Wire
- 7 weeks ago - Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025 - Business Wire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Shareholders to Connect - Accesswire
- 2 months ago - Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome - Business Wire